ZA885363B - Pharmaceutical compositions for the treatment of uraemia - Google Patents

Pharmaceutical compositions for the treatment of uraemia

Info

Publication number
ZA885363B
ZA885363B ZA885363A ZA885363A ZA885363B ZA 885363 B ZA885363 B ZA 885363B ZA 885363 A ZA885363 A ZA 885363A ZA 885363 A ZA885363 A ZA 885363A ZA 885363 B ZA885363 B ZA 885363B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
uraemia
treatment
amino acids
alpha
Prior art date
Application number
ZA885363A
Other languages
English (en)
Inventor
Christian Melin
Melin Christian
Jean-Marc Bobee
Bobee Jean-Marc
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9353446&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA885363(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA885363B publication Critical patent/ZA885363B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA885363A 1987-07-23 1988-07-22 Pharmaceutical compositions for the treatment of uraemia ZA885363B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8710406A FR2618331B1 (fr) 1987-07-23 1987-07-23 Compositions pharmaceutiques utiles pour le traitement de l'uremie

Publications (1)

Publication Number Publication Date
ZA885363B true ZA885363B (en) 1989-03-29

Family

ID=9353446

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885363A ZA885363B (en) 1987-07-23 1988-07-22 Pharmaceutical compositions for the treatment of uraemia

Country Status (14)

Country Link
US (1) US4908214A (pt)
EP (1) EP0300878B1 (pt)
JP (1) JPS6434916A (pt)
KR (1) KR890001535A (pt)
AT (1) ATE69164T1 (pt)
AU (1) AU599255B2 (pt)
CA (1) CA1329773C (pt)
DE (1) DE3866045D1 (pt)
DK (1) DK412788A (pt)
FR (1) FR2618331B1 (pt)
NO (1) NO883261L (pt)
NZ (1) NZ225526A (pt)
PT (1) PT88086A (pt)
ZA (1) ZA885363B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04159219A (ja) * 1990-10-23 1992-06-02 Otsuka Pharmaceut Factory Inc 腎不全用経口アミノ酸製剤
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
ES2245780T3 (es) * 1994-05-18 2006-01-16 Nektar Therapeutics Metodos y composiciones para la formulacion de interferones como un polvo seco.
DE19721206A1 (de) * 1997-05-21 1998-11-26 Babcock Kraftwerkstech Gmbh Vorrichtung zur Entnahme und Kühlung von Bettasche aus einer Wirbelschichtfeuerung
GB9801363D0 (en) * 1998-01-22 1998-03-18 Danbiosyst Uk Novel dosage form
ES2284643T3 (es) 2000-04-20 2007-11-16 Novartis Ag Composicion de revestimiento enmascarante del sabor.
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
EP1377339A4 (en) * 2001-04-04 2006-05-31 Critical Therapeutics Inc PROCEDURE FOR PREVENTING AKUTER NIERENINSUFFIZIENZ
JPWO2004078171A1 (ja) * 2003-03-06 2006-06-08 協和醗酵工業株式会社 吸水性アミノ酸含有錠剤
KR20070100686A (ko) * 2004-09-07 2007-10-11 오르펀 메디칼, 인크. 개선된 ｇｈｂ 조성물
WO2012137216A1 (en) * 2011-04-06 2012-10-11 Rpg Life Sciences Limited A novel pharmaceutical formulation of alpha ketoanalogue of amino acids and additional amino acids for treatment of chronic kidney disease and method of preparation thereof
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compositions for the treatment of liver disease
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
FR2315916A2 (fr) * 1976-03-23 1977-01-28 Univ Johns Hopkins Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree
US4228099A (en) * 1978-03-17 1980-10-14 The Johns Hopkins University Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
US4320146A (en) * 1978-03-17 1982-03-16 The Johns Hopkins University Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
US4352814A (en) * 1979-04-18 1982-10-05 The Johns Hopkins University Treatment of hepatic and renal disorders with mixed salts of essential or semi-essential amino acids and nitrogen-free analogs
JPS60237054A (ja) * 1984-05-10 1985-11-25 Nippon Kayaku Co Ltd アミノ酸の晶析法
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
IT1177384B (it) * 1984-12-12 1987-08-26 Boeehringer Biochemia Robin Sp Prodotti dietetici granulari a base di amminoacidi e procedimento per la loro preparazione
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia

Also Published As

Publication number Publication date
KR890001535A (ko) 1989-03-27
DK412788D0 (da) 1988-07-22
EP0300878B1 (fr) 1991-11-06
CA1329773C (fr) 1994-05-24
EP0300878A1 (fr) 1989-01-25
JPS6434916A (en) 1989-02-06
AU1971988A (en) 1989-01-27
US4908214A (en) 1990-03-13
DK412788A (da) 1989-01-24
FR2618331A1 (fr) 1989-01-27
PT88086A (pt) 1989-06-30
NZ225526A (en) 1990-06-26
NO883261L (no) 1989-01-23
ATE69164T1 (de) 1991-11-15
DE3866045D1 (de) 1991-12-12
FR2618331B1 (fr) 1991-10-04
NO883261D0 (no) 1988-07-22
AU599255B2 (en) 1990-07-12

Similar Documents

Publication Publication Date Title
ZA885363B (en) Pharmaceutical compositions for the treatment of uraemia
PT82841A (en) Process for the preparation of novel amino acid derivatives and of pharmaceutical compositions containing the same
GR3007202T3 (pt)
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
IL95158A0 (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine
IL80900A (en) Pharmaceutical composition containing fibrinolytic compounds and carbacyclin analogues for treatment of thrombosis
HUT38255A (en) Process for preparing pharmaceutical compositions containing pyrimido-pyrimidines and o-acetyl-salicylic acid resp. pharmaceutically acceptable salts thereof
IL95849A0 (en) Pharmaceutical combination containing acetylsalicylic acid and carbacyclin derivatives
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
EP0515995A3 (en) N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
ZA877901B (en) Active compounds for use in the treatment of tumors
GR3007995T3 (pt)
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
EP0624368A3 (en) Use of a composition to stimulate glutathione synthesis for the manufacture of a medicament for the treatment of AID.
AU1621888A (en) Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
IT1271354B (it) Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi
IT1255380B (it) Nitrobenzoilalanine,procedimento per la loro preparazione,loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono
ZA892712B (en) Oral pharmaceutical for the once-a-day treatment of hypertonia with diltiazem-hydrochloride
IL86116A0 (en) Pharmaceutical compositions for the treatment of malaria